KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Net Cash Flow (2016 - 2026)

Medtronic's Net Cash Flow history spans 13 years, with the latest figure at -$159.0 million for Q1 2026.

  • For Q1 2026, Net Cash Flow fell 562.5% year-over-year to -$159.0 million; the TTM value through Jan 2026 reached -$428.0 million, down 88.55%, while the annual FY2025 figure was $746.0 million, 2672.41% up from the prior year.
  • Net Cash Flow for Q1 2026 was -$159.0 million at Medtronic, down from $48.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $2.8 billion in Q4 2022 and bottomed at -$2.9 billion in Q2 2023.
  • The 5-year median for Net Cash Flow is -$4.0 million (2024), against an average of -$107.5 million.
  • The largest annual shift saw Net Cash Flow skyrocketed 3036.84% in 2022 before it tumbled 25200.0% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $2.8 billion in 2022, then crashed by 94.73% to $147.0 million in 2023, then crashed by 46.26% to $79.0 million in 2024, then tumbled by 39.24% to $48.0 million in 2025, then crashed by 431.25% to -$159.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Net Cash Flow are -$159.0 million (Q1 2026), $48.0 million (Q4 2025), and -$1.0 billion (Q3 2025).